Back to Search
Start Over
SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients
- Source :
- Journal of the International AIDS Society
- Publication Year :
- 2010
- Publisher :
- The International AIDS Society, 2010.
-
Abstract
- The objective of this study was to evaluate the efficacy, tolerability, and safety of fosamprenavir/ritonavir (FPV/r) versus efavirenz (EFV), both in combination with abacavir/lamivudine (ABC/3TC), in a population that is often underrepresented in U.S. clinical trials. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published: 8 November 2010) doi:10.1186/1758-2652-13-S4-P7 Cite this article as: Kumar et al.: SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naive patients. Journal of the International AIDS Society 2010 13(Suppl 4):P7. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113075/
- Subjects :
- medicine.medical_specialty
Efavirenz
Population
Fosamprenavir
Pharmacology
chemistry.chemical_compound
immune system diseases
Abacavir
Internal medicine
parasitic diseases
medicine
heterocyclic compounds
education
education.field_of_study
business.industry
Public Health, Environmental and Occupational Health
virus diseases
Lamivudine
Abacavir/Lamivudine
biochemical phenomena, metabolism, and nutrition
Infectious Diseases
Tolerability
chemistry
Poster Presentation
Ritonavir
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 17582652
- Volume :
- 13
- Issue :
- Suppl 4
- Database :
- OpenAIRE
- Journal :
- Journal of the International AIDS Society
- Accession number :
- edsair.doi.dedup.....d589566b9ee3ad303aab699816be229e